drugdeliverybusiness3h
Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue
Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.
drugdeliverybusiness4d
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
drugdeliverybusiness5d
Micron Biomedical raises $33M for needle-free drug delivery tech
Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 ...
drugdeliverybusiness5d
Analysts say Embecta is ‘heading in the right direction’ following patch pump discontinuation
Analysts called a stock sell-off at Embecta "unwarranted" and believe the company is moving in the right direction despite recent challenges.
drugdeliverybusiness4d
Dexcom inks glucose biosensor partnership with Life Time
Dexcom (Nasdaq:DXCM) announced that it entered into a new partnership with Life Time Inc., an operator of athletic country clubs.
drugdeliverybusiness6d
Aerosol drug delivery company Aerogen to expand in Ireland
[Image from Aerogen] Aerogen announced today that it plans to invest about $308.5 million (€300 million) to expand operations in Ireland. The company — headquartered in Dangan, Galway — expects its ...